The purpose of the study is to evaluate an investigational device that delivers the FDA approved drug Migranal (Dihydroergotamine Mesylate) intranassaly in adults with migraine headaches. The study will last 24 to 52 weeks with 9 to 12 visits to the study site. While in the study, your study-related visits, study-related drug-device, lab work and procedures are provided at no charge. If you do qualify and enroll, you will be compensated up to $1080 for your time and travel.
Male and Female
Why take part?
Participants will receive study-related doctor’s care, study medication at no cost. Compensation for study-related time and travel may be available.Millions of people lack the treatment they need to manage their conditions. As one of the largest and most recognized clinical study organisations in the world, Synexus provides a friendly relaxed environment where you have the opportunity to help others and maybe also yourself.
Who is Synexus?
Synexus is a company dedicated to conducting clinical studies, and has been investigating the effectiveness of new study drugs and treatments for more than 20 years. We provide a friendly, relaxed environment in our own clinics where you have the chance to help shape the future of health for yourself and for others.We are sure you probably have more questions about the study, and we would be happy to take the time to give you more details.
All Synexus studies are approved by an independent ethics committee.